Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set

E. A. Klein, D. Richards, A. Cohn, M. Tummala, R. Lapham, D. Cosgrove, G. Chung, J. Clement, J. Gao, N. Hunkapiller, A. Jamshidi, K. N. Kurtzman, M. V. Seiden, C. Swanton & M. C. Liu

Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland; The US Oncology Network, Tyler; The US Oncology Network, Denver; Mercy Clinic Cancer Center, Springfield; Spartanburg Regional Healthcare System, Spartanburg; Compass Oncology, Vancouver; The Christ Hospital Health Network, Cincinnati; Hartford HealthCare Cancer Institute, Hartford; GRAIL, Inc., Menlo Park; US Oncology Research, The Woodlands, USA; The Francis Crick Institute, London; University College London Cancer Institute, London, UK; Mayo Clinic, Rochester, USA

(Bold indicates GRN Partner Health Systems)